Investment.com – Allergan (NYSE:AGN_pa) to buy Tobira Therapeutics Inc (NASDAQ:TBRA) for up to $1.7 bn.
Tobira, a NASH fatty liver disease experimental therapies firm soared 655% to $35.80 at 09:45 ET.
Allergan's offer of $28.35 per Tobira share at near 500% premium to Monday closing price.
Tobira shareholders could get up to $49.84/share if milestones achieved.
Some 30% of people in U.S. suffer from fatty liver diseases such as NASH.